+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Clinical Development"

From
STAT3 Inhibitors Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

STAT3 Inhibitors Market Opportunity & Clinical Trials Insight 2028

  • Report
  • February 2025
  • 100 Pages
  • Global
From
From
From
From
CD137 Antibodies Clinical Trials & Market Opportunity Insight - Product Thumbnail Image

CD137 Antibodies Clinical Trials & Market Opportunity Insight

  • Report
  • September 2024
  • 210 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Clinical Development market is a key component of the Drug Discovery process. It involves the testing of new drugs and treatments on human subjects in order to assess their safety and efficacy. Clinical Development typically involves a series of phases, beginning with pre-clinical trials and progressing through to Phase I, II, and III clinical trials. The results of these trials are used to determine whether a drug should be approved for use by regulatory authorities. The Clinical Development market is highly competitive, with a range of companies offering services such as clinical trial design, data management, and regulatory consulting. These companies are often specialized in specific therapeutic areas, such as oncology, neurology, and cardiology. Examples of companies in the Clinical Development market include Parexel, ICON, and Syneos Health. Show Less Read more